Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04603196 · ClinicalTrials.gov registry record
Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis
A clinical trial of Multiple Sclerosis and Obstructive Sleep Apnea, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT04603196 is a study of Multiple Sclerosis and Obstructive Sleep Apnea that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 800 participants, above the 583-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04603196, a study of Multiple Sclerosis and Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.
Conditions Studied
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2030-06-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04603196
The ClinicalTrials.gov registry entry for NCT04603196 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 583-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (37% higher). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT04603196 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04603196 about?
NCT04603196 is a clinical study titled "Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis". This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and...
What is the current status of trial NCT04603196?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2019-06-20. Estimated completion is 2030-06-20.
What conditions does trial NCT04603196 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Obstructive Sleep Apnea.
Who is sponsoring clinical trial NCT04603196?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04603196 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.